Study reveals mechanism of lung-cancer drug resistance
New research published in Nature Medicine indicates that targeted drugs such as gefitinib might more effectively treat non-small cell lung cancer if they could be combined with agents that block certain microRNAs....
Source: PhysOrg - Thursday, 19 January
Related articles:
- Less than a few days ago
- 2Vote! Researchers discover drug destroys human cancer stem cells but not healthy ones
LabSpaces - 2 days ago
- 2Vote! Drug-vaccine combo better for breast cancer
Futurity.org - 3 days ago
- 4Vote! Researchers create new anti-cancer drug
- 3Vote! Human study will test drug to prevent Alzheimer’s
- 3Vote! 'Orphan' sleep drug may be potent cancer-fighting agent
- Less than a week ago
- 2Vote! Castor oil: Action mechanism of one of the oldest drugs known to man elucidated
PhysOrg - 5 days ago
- 3Vote! Blocking DNA: HDAC inhibitor targets triple negative breast cancer
- Older News
- 5Vote! New key mechanism in cell division discovered
- 5Vote! Cancer vaccine combination therapy shows survival benefit in breast cancer
- 5Vote! Mystery gene reveals new mechanism for anxiety disorders
- 9Vote! Drug kills cancer cells by restoring faulty tumor suppressor
- 3Vote! 'One in six cancers worldwide are caused by infection' -- BBC News
Harvard World Health News - Friday, 11 May
- 1Vote! New bacterium forms intracellular minerals
- 2Vote! Research reveals novel transport mechanism for large ribonucleoproteins
- 4Vote! Droplet array sheds light on drug-resistant cancer stem cells
- 10Vote! Scientists aim to kill lung tumors
- 7Vote! MicroRNA controls malignancy and resistance of breast cancer cells
- 4Vote! Study discovers genetic pathway impacting the spread of cancer cells
- 4Vote! UNC study shows potential to revive abandoned cancer drug by nanoparticle drug delivery
e! Science News - Wednesday, 2 May
- 4Vote! Study shows potential to revive abandoned cancer drug by nanoparticle drug delivery
